Acid suppression therapy impairs sunitinib efficacy in renal cell cancer (RCC)

被引：0
|
作者：
Chu, Michael P. [1 ]
Ha, Vincent [1 ]
Ngo, Margaret [2 ]
Ghosh, Sunita [1 ]
Chambers, Carole R. [2 ]
Sawyer, Michael B. [1 ]
机构：
[1] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[2] Tom Baker Canc Clin, Calgary, AB, Canada
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-4628
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4628
引用
收藏
页数：2
相关论文
共 50 条
  • [1] THE EFFICACY OF SUNITINIB IN TARGETED THERAPY OF METASTATIC RENAL CELL CANCER
    Kalpinskiy, A. S.
    Alekseev, B. Y.
    ONKOUROLOGIYA, 2009, 5 (03): : 62 - 66
  • [2] Does gastric acid suppression affect sunitinib efficacy in patients with advanced or metastatic renal cell cancer?
    Ha, Vincent H.
    Ngo, Margaret
    Chu, Michael P.
    Ghosh, Sunita
    Sawyer, Michael B.
    Chambers, Carole R.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2015, 21 (03) : 194 - 200
  • [3] ACID SUPPRESSION THERAPY IMPAIRS ERLOTINIB EFFICACY IN NON-SMALL CELL LUNG CANCER
    Chu, Michael P.
    Ghosh, Sunita
    Chambers, Carole
    Basappa, Naveen
    Butts, Charles A.
    Chu, Quincy
    Fenton, David
    Joy, Anil A.
    Sangha, Randeep
    Smylie, Michael
    Sawyer, Michael B.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S912 - S912
  • [4] Sunitinib malate (SU11248) - Efficacy in renal cell carcinoma (RCC)
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 287 - 287
  • [5] Sunitinib-related macrocytosis in patients with advanced renal cell cancer (RCC)
    Price, J. A.
    Shaarbaf, R.
    Wood, L. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Outcomes of systemic therapy in relapsed renal cell carcinoma (RCC) treated with adjuvant sunitinib (AS)
    de Velasco, Guillermo
    Ruiz-Granados, Alvaro
    Reig, Oscar
    Massari, Francesco
    Duran, Miguel Angel Climent
    Verzoni, Elena
    Graham, Jeffrey
    Llarena, Roberto
    De Tursi, Michele
    Donskov, Frede
    Iglesias, Clara
    Pandha, Hardev S.
    del Muro, Xavier Garcia
    Procopio, Giuseppe
    Oudard, Stephane
    Castellano, Daniel
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [7] Efficacy and toxicity of sunitinib for non clear cell renal cell carcinoma (RCC): A systematic review of the literature
    Abdel-Rahman, Omar
    Fouad, Mona
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 94 (02) : 238 - 250
  • [8] Evaluation of thyroid dysfunction as a candidate surrogate marker for efficacy of sunitinib in patients (pts) with advanced renal cell cancer (RCC)
    Wolter, P.
    Stefan, C.
    Decallonne, B.
    Dumez, H.
    Fieuws, S.
    Wildiers, H.
    Clement, P.
    Debaere, D.
    Van Oosterom, A.
    Schoffski, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] To compare the efficacy and safety of pazopanib and sunitinib in metastatic renal cell carcinoma (RCC) of Chinese population
    Chan, M. F. T.
    Lam, Q. Y. N.
    Lee, V. H. F.
    Siu, S. W. K.
    Kwong, P. W. K.
    Leung, T. W.
    ANNALS OF ONCOLOGY, 2015, 26 : 77 - 77
  • [10] Renal transplantation as a renal replacement therapy in patients with renal cell cancer (RCC)
    Borkowski, Andrzej
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2005, 9 (03): : 106 - 109
12345